Cholesterol Esterase antibody (Biotin)

Catalog No. ABIN289960

Product Details anti-Cholesterol Esterase Antibody (Biotin)

Target: Cholesterol Esterase (CEL)

Reactivity: All Species

Host: Mouse

Clonality: Monoclonal

Conjugate: This Cholesterol Esterase antibody is conjugated to Biotin

Application: ELISA, Immunohistochemistry (IHC)

Purification: The splenic lymphocytes from BALB/c mouse, immunized with CEL-BSA were fused to myelomaP3U1 cells. The cell line (KNH-30) with positive reaction was grown in ascitic fluid of BALB/cmouse, from which the antibody was purified by Protein G affinity chromatography and conjugated.

Immunogen: CEL-BSA

Clone: KNH-30

Isotype: IgG1

Application Details

Application Notes: Working dilution for immunohistochemistry: 5-10ug/ml, for ELISA: 0.1-1.0ug/ml

Restrictions: For Research Use only

Handling

Concentration: 0.25 mg/ml

Buffer: PBS (containing 2% Block Ace as a stabilizer, 0.1% Proclin as a bacteriostat)

Preservative: ProClin

Storage: -20 °C

Target Details for Cholesterol Esterase

Target: Cholesterol Esterase (CEL)

Alternative Name: CEL (CEL Products)

Synonyms: SC8F4.24 antibody, BAL antibody, BSDL antibody, BSSL antibody, CELL antibody, CEase antibody, FAP antibody, FAPP antibody, LIPA antibody, MODY8 antibody, 1810036E18Rik antibody, Bal antibody, Bssl antibody, carboxyl ester lipase antibody, cholesterol esterase antibody, hypothetical protein antibody, CEL antibody, SCO5420 antibody, Tfu_2331 antibody, SARE_RS01070 antibody, RSal33209_1252 antibody, Caci_5976 antibody, Ndas_0054 antibody, Micau_5972 antibody, ML5_2523 antibody, Cel antibody, cel antibody

Background: Reaction of protein amino groups with glucose leads, through the early products such as a Schiff base andAmadori rearrangement products, to the formation of advanced glycation end products (AGEs). Recentimmunological studies using anti-AGEs antibody (6D12) demonstrated the presence of AGEs-modified proteinsin several human tissues: human lens (nondiabetic and noncataractous), renal proximal tubules inpatients with diabetic nephropathy and chronic renal failure, diabetic retina, peripheral nerves ofdiabetic neuropathy, atherosclerotic lesions of arterial walls, beta2-microglobulin forming amyloid fibrilsin patients with hemodialysis-related amyloidosis, senile plaques of patients with Alzheimer

Pathways: Lipid Metabolism